SCHEMBL17734747

SCHEMBL17734747

Cc1cc(-c2cc(C)c(N(c3ccc4oc5ccc(-c6ccccc6)cc5c4c3)c3ccccc3-c3ccccc3)c(C)c2)cc(C)c1N(c1ccc2oc3ccc(-c4ccccc4)cc3c2c1)c1ccccc1-c1ccccc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 3/20 0.35
▸ PLA2G4A P47712 3/20 0.35
▸ GAA P10253 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ MAPT P10636 4/20 0.33
▸ PRKDC P78527 3/20 0.33
▸ CYP1A1 P04798 2/20 0.33
▸ CYP1A2 P05177 2/20 0.33
▸ CYP1B1 Q16678 2/20 0.33
▸ KDM4E B2RXH2 3/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ HPGD P15428 2/20 0.33
▸ TP53 P04637 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ PIM1 P11309 1/20 0.32
▸ CSNK2A2 P19784 1/20 0.32
▸ CSNK2B P67870 1/20 0.32
▸ PIM3 Q86V86 1/20 0.32
▸ PIM2 Q9P1W9 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17734734 0.93 PLA2G2A (0.38) PLA2G2APLA2G4AGAAL3MBTL1MAPT
SCHEMBL17734707 0.92 MAOA (0.36) L3MBTL1MAPTCYP1A1CYP1A2CYP1B1
SCHEMBL17734594 0.91 PLA2G2A (0.35) PLA2G2APLA2G4AGAAL3MBTL1MAPT
SCHEMBL17734748 0.90 PLA2G2A (0.36) PLA2G2APLA2G4AGAAL3MBTL1MAPT
SCHEMBL17734681 0.88 PLA2G2A (0.35) PLA2G2APLA2G4AGAAL3MBTL1MAPT
SCHEMBL17734810 0.87 MAPT (0.37) PLA2G2APLA2G4AGAAL3MBTL1MAPT
SCHEMBL17734848 0.86 PLA2G2A (0.36) PLA2G2APLA2G4AGAAL3MBTL1MAPT
SCHEMBL17734518 0.85 MAOA (0.35) PLA2G2APLA2G4AGAAL3MBTL1MAPT
SCHEMBL18212124 0.84 PLA2G2A (0.42) PLA2G2APLA2G4AMAPTPRKDCCYP1A2
SCHEMBL17734859 0.84 PLA2G2A (0.38) PLA2G2APLA2G4AGAAL3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160133847-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2016-05-12 — — US disclosed
US-20160133847-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2016-05-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160133847-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT ARL1, CCNL2, APOL1 PLA2G2A 3496/4885PLA2G4A 3820/4885GAA 4060/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback